Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 486148, 10 pages
http://dx.doi.org/10.1155/2015/486148
Research Article

Glutathione Supplementation Attenuates Oxidative Stress and Improves Vascular Hyporesponsiveness in Experimental Obstructive Jaundice

1Department of Anesthesia & Intensive Care, Eastern Hepatobiliary Surgery Hospital, the Second Military Medical University, Shanghai 200438, China
2Department of Anesthesiology, 81st Hospital of the Chinese PLA, Nanjing 210002, China

Received 24 September 2014; Revised 31 January 2015; Accepted 31 January 2015

Academic Editor: Yanfang Chen

Copyright © 2015 Jiaying Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. B. Ballinger, J. A. Woolley, M. Ahmed et al., “Persistent systemic inflammatory response after stent insertion in patients with malignant bile duct obstruction,” Gut, vol. 42, no. 4, pp. 555–559, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Green and O. S. Better, “Systemic hypotension and renal failure in obstructive jaundice—mechanistic and therapeutic aspects,” Journal of the American Society of Nephrology, vol. 5, no. 11, pp. 1853–1871, 1995. View at Google Scholar · View at Scopus
  3. A. Kimmoun, N. Ducrocq, and B. Levy, “Mechanisms of vascular hyporesponsiveness in septic shock,” Current Vascular Pharmacology, vol. 11, no. 2, pp. 139–149, 2013. View at Google Scholar · View at Scopus
  4. B. L. Copple, H. Jaeschke, and C. D. Klaassen, “Oxidative stress and the pathogenesis of cholestasis,” Seminars in Liver Disease, vol. 30, no. 2, pp. 195–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. L. M. Yung, F. P. Leung, X. Yao, Z.-Y. Chen, and Y. Huang, “Reactive oxygen species in vascular wall,” Cardiovascular and Hematological Disorders-Drug Targets, vol. 6, no. 1, pp. 1–19, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Barón and P. Muriel, “Role of glutathione, lipid peroxidation and antioxidants on acute bile- duct obstruction in the rat,” Biochimica et Biophysica Acta—General Subjects, vol. 1472, no. 1-2, pp. 173–180, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Galicia-Moreno, L. Favari, and P. Muriel, “Antifibrotic and antioxidant effects of N-acetylcysteine in an experimental cholestatic model,” European Journal of Gastroenterology and Hepatology, vol. 24, no. 2, pp. 179–185, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. D. D. Rees, J. E. Monkhouse, D. Cambridge, and S. Moncada, “Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse,” British Journal of Pharmacology, vol. 124, no. 3, pp. 540–546, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. J. González, N. Valls, R. Brito, and R. Rodrigo, “Essential hypertension and oxidative stress: new insights,” World Journal of Cardiology, vol. 6, no. 6, pp. 353–366, 2014. View at Publisher · View at Google Scholar
  10. W. A. Boyle III, L. S. Parvathaneni, V. Bourlier, C. Sauter, V. E. Laubach, and J. P. Cobb, “iNOS gene expression modulates microvascular responsiveness in endotoxin-challenged mice,” Circulation Research, vol. 87, no. 7, pp. E18–E24, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Pacher, J. S. Beckman, and L. Liaudet, “Nitric oxide and peroxynitrite in health and disease,” Physiological Reviews, vol. 87, no. 1, pp. 315–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. L. Pall, “The NO/ONOO-cycle as the central cause of heart failure,” International Journal of Molecular Sciences, vol. 14, no. 11, pp. 22274–22330, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Çelebi, I. Yilmaz, H. Aksoy, M. Gümüş, S. Taysi, and D. Oren, “Dehydroepiandrosterone prevents oxidative injury in obstructive jaundice in rats,” Journal of International Medical Research, vol. 32, no. 4, pp. 400–405, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Carpenter-Deyo, D. H. Marchand, P. A. Jean, R. A. Roth, and D. J. Reed, “Involvement of glutathione in 1-naphthylisothiocyanate (ANIT) metabolism and toxicity to isolated hepatocytes,” Biochemical Pharmacology, vol. 42, no. 11, pp. 2171–2180, 1991. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Şener, O. Şehirli, H. Toklu, F. Ercan, and I. Alican, “Montelukast reduces ischaemia/reperfusion-induced bladder dysfunction and oxidant damage in the rat,” Journal of Pharmacy and Pharmacology, vol. 59, no. 6, pp. 837–842, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Perez, R. I. R. Macias, and J. J. G. Marin, “Maternal cholestasis induces placental oxidative stress and apoptosis. Protective effect of ursodeoxycholic acid,” Placenta, vol. 27, no. 1, pp. 34–41, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Engin and N. Altan, “Effects of obstructive jaundice on the antioxidative capacity of human red blood cells,” Haematologia (Budap), vol. 30, no. 2, pp. 91–96, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Ribas, C. García-Ruiz, and J. C. Fernández-Checa, “Glutathione and mitochondria,” Frontiers in Pharmacology, vol. 5, article 151, 2014. View at Publisher · View at Google Scholar
  19. A. Pompella, A. Visvikis, A. Paolicchi, V. De Tata, and A. F. Casini, “The changing faces of glutathione, a cellular protagonist,” Biochemical Pharmacology, vol. 66, no. 8, pp. 1499–1503, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Yu, P. Li, B. Wang, and K. Han, “Reversible near-infrared fluorescent probe introducing tellurium to mimetic glutathione peroxidase for monitoring the redox cycles between peroxynitrite and glutathione in vivo,” Journal of the American Chemical Society, vol. 135, no. 20, pp. 7674–7680, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Cao and Y. Li, “Protecting against peroxynitrite-mediated cytotoxicity in vascular smooth muscle cells via upregulating endogenous glutathione biosynthesis by 3H-1,2-dithiole-3-thione,” Cardiovascular Toxicology, vol. 4, no. 4, pp. 339–353, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. P. R. Ramires and L. L. Ji, “Glutathione supplementation and training increases myocardial resistance to ischemia-reperfusion in vivo,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 281, no. 2, pp. H679–H688, 2001. View at Google Scholar · View at Scopus
  23. F. T. Spradley, D. H. Ho, K.-T. Kang, D. M. Pollock, and J. S. Pollock, “Changing standard chow diet promotes vascular NOS dysfunction in Dahl S rats,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 302, no. 1, pp. R150–R158, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Omanwar, B. Saidullah, K. Ravi, and M. Fahim, “Modulation of vasodilator response via the nitric oxide pathway after acute methyl mercury chloride exposure in rats,” BioMed Research International, vol. 2013, Article ID 530603, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. T. P. Fernández, P. L. Serrano, E. Tomás et al., “Diagnostic and therapeutic approach to cholestatic liver disease,” Revista Española de Enfermedades Digestivas, vol. 96, no. 1, pp. 60–73, 2004. View at Google Scholar · View at Scopus
  26. P. Montilla, A. Cruz, F. J. Padillo et al., “Melatonin versus vitamin E as protective treatment against oxidative stress after extra-hepatic bile duct ligation in rats,” Journal of Pineal Research, vol. 31, no. 2, pp. 138–144, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. F. J. Padillo, M. Rodriguez, J. M. Gallardo et al., “Preoperative assessment of body fluid disturbances in patients with obstructive jaundice,” World Journal of Surgery, vol. 23, no. 7, pp. 681–687, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. H. S. Basaga, “Biochemical aspects of free radicals,” Biochemistry and Cell Biology, vol. 68, no. 7-8, pp. 989–998, 1990. View at Publisher · View at Google Scholar · View at Scopus
  29. J. S. Beckman and W. H. Koppenol, “Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly,” The American Journal of Physiology—Cell Physiology, vol. 271, no. 5, pp. C1424–C1437, 1996. View at Google Scholar · View at Scopus
  30. R. Radi, A. Cassina, R. Hodara, C. Quijano, and L. Castro, “Peroxynitrite reactions and formation in mitochondria,” Free Radical Biology and Medicine, vol. 33, no. 11, pp. 1451–1464, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Virág, É. Szabó, P. Gergely, and C. Szabó, “Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention,” Toxicology Letters, vol. 140-141, pp. 113–124, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Radi, J. S. Beckman, K. M. Bush, and B. A. Freeman, “Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide,” The Journal of Biological Chemistry, vol. 266, no. 7, pp. 4244–4250, 1991. View at Google Scholar · View at Scopus
  33. B. Alvarez and R. Radi, “Peroxynitrite reactivity with amino acids and proteins,” Amino Acids, vol. 25, no. 3-4, pp. 295–311, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Li, D. D. Gutterman, N. J. Rusch, A. Bubolz, and Y. Liu, “Nitration and functional loss of voltage-gated K+ channels in rat coronary microvessels exposed to high glucose,” Diabetes, vol. 53, no. 9, pp. 2436–2442, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Nomiyama, Y. Igarashi, H. Taka et al., “Reduction of insulin-stimulated glucose uptake by peroxynitrite is concurrent with tyrosine nitration of insulin receptor substrate-1,” Biochemical and Biophysical Research Communications, vol. 320, no. 3, pp. 639–647, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Takakura, T. Taniguchi, I. Muramatsu, K. Takeuchi, and S. Fukuda, “Modification of α1-adrenoceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis,” Critical Care Medicine, vol. 30, no. 4, pp. 894–899, 2002. View at Google Scholar · View at Scopus
  37. S. J. Lewis, A. Hoque, K. Sandock, T. P. Robertson, J. N. Bates, and N. W. Kooy, “Differential effects of peroxynitrite on the function of arginine vasopressin V1a receptors and alpha1-adrenoceptors in vivo,” Vascular Pharmacology, vol. 46, no. 1, pp. 24–34, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. S. J. Lewis, A. Hoque, T. M. Walton, and N. W. Kooy, “Potential role of nitration and oxidation reactions in the effects of peroxynitrite on the function of beta-adrenoceptor sub-types in the rat,” European Journal of Pharmacology, vol. 518, no. 2-3, pp. 187–194, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Duplain, C. Sartori, P. Dessen et al., “Stimulation of peroxynitrite catalysis improves insulin sensitivity in high fat diet-fed mice,” The Journal of Physiology, vol. 586, no. 16, pp. 4011–4016, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Dalle-Donne, R. Rossi, R. Colombo, D. Giustarini, and A. Milzani, “Biomarkers of oxidative damage in human disease,” Clinical Chemistry, vol. 52, no. 4, pp. 601–623, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. M. D. C. Martín, G. Balfagón, N. Minoves, J. Blanco-Rivero, and M. Ferrer, “Androgen deprivation increases neuronal nitric oxide metabolism and its vasodilator effect in rat mesenteric arteries,” Nitric Oxide, vol. 12, no. 3, pp. 163–176, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. P. Panozzo, D. Basso, L. Balint et al., “Altered lipid peroxidation/glutathione ratio in experimental extrahepatic cholestasis,” Clinical and Experimental Pharmacology and Physiology, vol. 22, no. 4, pp. 266–271, 1995. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Dirlik, H. Canbaz, D. Düşmez Apa et al., “The monitoring of progress in apoptosis of liver cells in bile duct-ligated rats,” Turkish Journal of Gastroenterology, vol. 20, no. 4, pp. 247–256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. P. M. Lopze, I. T. Fiñana, M. C. M. de Agueda et al., “Protective effect of melatonin against oxidative stress induced by ligature of extra-hepatic biliary duct in rats: comparison with the effect of S-adenosyl-L-methionine,” Journal of Pineal Research, vol. 28, no. 3, pp. 143–149, 2000. View at Google Scholar · View at Scopus
  45. J.-M. Sheen, L.-T. Huang, C.-S. Hsieh, C.-C. Chen, J.-Y. Wang, and Y.-L. Tain, “Bile duct ligation in developing rats: temporal progression of liver, kidney, and brain damage,” Journal of Pediatric Surgery, vol. 45, no. 8, pp. 1650–1658, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Orellana, R. Rodrigo, L. Thielemann, and V. Guajardo, “Bile duct ligation and oxidative stress in the rat: effects in liver and kidney,” Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology, vol. 126, no. 2, pp. 105–111, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. E. Purucker, R. Winograd, E. Roeb, and S. Matern, “Glutathione status in liver and plasma during development of biliary cirrhosis after bile duct ligation,” Research in Experimental Medicine, vol. 198, no. 4, pp. 167–174, 1998. View at Publisher · View at Google Scholar · View at Scopus
  48. B. A. Neuschwander-Tetri, C. Nicholson, L. D. Wells, and T. F. Tracy Jr., “Cholestatic liver injury down-regulates hepatic glutathione synthesis,” Journal of Surgical Research, vol. 63, no. 2, pp. 447–451, 1996. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Wu, X.-W. Xu, X.-R. Miao, L.-Q. Yang, Q. Li, and W.-F. Yu, “Changes of vasoconstrictor and vasodilator functions of isolated thoracic aorta rings in rats with obstructive jaundice,” Academic Journal of Second Military Medical University, vol. 30, no. 2, pp. 162–165, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Takaki, K. Morikawa, Y. Murayama et al., “Roles of endothelial oxidases in endothelium-derived hyperpolarizing factor responses in mice,” Journal of Cardiovascular Pharmacology, vol. 52, no. 6, pp. 510–517, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. L.-N. Zhang, J. Vincelette, D. Chen et al., “Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension,” European Journal of Pharmacology, vol. 654, no. 1, pp. 68–74, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Roghani and T. Baluchnejadmojarad, “Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms,” Vascular Pharmacology, vol. 51, no. 2-3, pp. 84–89, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. V. Poppa, J. K. Miyashiro, M. A. Corson, and B. C. Berk, “Endothelial NO synthase is increased in regenerating endothelium after denuding injury of the rat aorta,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 8, pp. 1312–1321, 1998. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Gericke, E. Goloborodko, J. J. Sniatecki, A. Steege, L. Wojnowski, and N. Pfeiffer, “Contribution of nitric oxide synthase isoforms to cholinergic vasodilation in murine retinal arterioles,” Experimental Eye Research, vol. 109, pp. 60–66, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Tian, Z. Yan, Y. Wu et al., “Inhibition of iNOS protects endothelial-dependent vasodilation in aged rats,” Acta Pharmacologica Sinica, vol. 31, no. 10, pp. 1324–1328, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. K. Takagi, Y. Kawaguchi, M. Hara, T. Sugiura, M. Harigai, and N. Kamatani, “Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features,” Clinical and Experimental Immunology, vol. 134, no. 3, pp. 538–544, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. J. B. Majithiya, A. N. Paramar, and R. Balaraman, “Pioglitazone, a PPARγ agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats,” Cardiovascular Research, vol. 66, no. 1, pp. 150–161, 2005. View at Publisher · View at Google Scholar · View at Scopus